Quest Diagnostics, Inc. (DGX) Misses Q2 EPS by 4c; Guides In-Line

July 18, 2013 7:02 AM

Quest Diagnostics, Inc. (NYSE: DGX) reported Q2 EPS of $1.06, $0.04 worse than the analyst estimate of $1.10. Revenue for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found